Manuel García-Delgado

Dr. Manuel García-Delgado


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
MGManuel García-Delgado
Manuel García-Delgado
DGD. García-Huertas
D. García-Huertas
INI. Navarrete-Sánchez
I. Navarrete-Sánchez
LOL. Olivencia-Peña
L. Olivencia-Peña
JGJ.M. Garrido
J.M. Garrido

1 January 2017 in SDRP Journal of Anesthesia & Surgery
Verified
Journal Article
Open access
PDF file
MOMaría Redondo Orts
María Redondo Orts
MRMaría Redondo-Orts
María Redondo-Orts
MGManuel García-Delgado
Manuel García-Delgado
INInés Navarrete-Sánchez\R\N
Inés Navarrete-Sánchez\R\N
SDSift Desk
Sift Desk
Sift Desk Research Page is fully open access journals.

6 February 2025 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
MGManuel García-Delgado
Manuel García-Delgado
VCVioleta Chica-Sáez
Violeta Chica-Sáez
AFAndrea Ferreiro-Marzal
Andrea Ferreiro-Marzal
MRMaría Redondo-Orts
María Redondo-Orts
MEMaría Esteban-Molina
María Esteban-Molina
JGJosé Manuel Garrido-Jiménez
José Manuel Garrido-Jiménez

24 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LBLuis Baeza
Luis Baeza
Pablo AvanzasPablo Avanzas
Pablo Avanzas
CMCarla Delgado Martí
Carla Delgado Martí
MGManuel García-Delgado
Manuel García-Delgado
SESantiago Gómez Estanga
Santiago Gómez Estanga
Marc VivesMarc Vives
Marc Vives
Cardiac surgery-associated acute kidney injury (CS-AKI) increases short- and long-term mortality, progression to chronic kidney disease (CKD), and healthcare costs. Its pathogenesis is multifactorial—combining renal hypoperfusion, impaired oxygen delivery, hemodilution, inflammation, ischemia–reperfusion injury, and nephrotoxin exposure—so no single intervention confers universal protection. This narrative review appraises fourteen perioperative prevention strategies, grading each by study design, reproducibility, and concordance with contemporary guidelines. The strongest actionable evidence supports the preservation of renal oxygen delivery during cardiopulmonary bypass through goal-directed perfusion, perioperative amino acid infusion, and biomarker-guided Kidney Disease: Improving Global Outcomes (KDIGO) care bundles. Remote ischemic preconditioning, pulsatile flow, minimally invasive extracorporeal circulation, dexmedetomidine, N-acetylcysteine, levosimendan, hemoadsorption with the oXiris membrane, and natriuretic peptides show variable or subgroup-dependent signals limited by heterogeneous trial design and acute kidney injury (AKI) definitions. Prevention of CS-AKI is, therefore, best conceived as a multimodal, patient-centered process integrating preoperative risk stratification, intraoperative oxygen delivery optimization, patient blood management (PBM), and postoperative nephrotoxin avoidance and surveillance.